Condensed Balance Sheets (USD $)	Apr. 30, 2013	Jul. 31, 2012
Current Assets
Cash	$ 125	$ 434
Total Assets	125	434
Current Liabilities
Accounts Payable & Accrued Expenses	220,931	139,402
Accrued Interest Payable	1,893	937
Notes Payable	26,034	20,000
Total Liabilities	248,858	160,339
Commitments and Contingencies (See Note 4)
Stockholders' Deficiency
Preferred stock, $0.0001 par value; 10,000,000 shares authorized, none issued and outstanding
Common stock, $0.0001 par value; 100,000,000 shares authorized, 18,077,550 shares and 18,077,550 issued and outstanding, respectively	1,808	1,808
Additional paid-in capital	794,060	782,193
Deficit accumulated during the development stage	(1,044,601)	(943,906)
Total Stockholders' Deficiency	(248,733)	(159,905)
Total Liabilities and Stockholders' Deficiency	125	434
Common Stock [Member]
Stockholders' Deficiency
Total Stockholders' Deficiency	$ 1,808	$ 1,808